Secondary outcomes were serious adverse events , related serious adverse events ( deemed attributable to study participation ) , pain ( assessed on an 11-point visual-analogue scale , with higher scores indicating more severe pain ) , return emergency department visits , hospitalizations , and diagnostic accuracy .